Structure's lead candidate, aleniglipron, an oral GLP-1R agonist, shows potential in obesity treatment, with significant Phase 2 data expected in Q4 2025. Despite a crowded GLP-1 drug development ...

Researchers found that cooperative fluid dynamics between single-celled organisms may have driven the evolution of ...

Orthodontic treatment does more than straighten teeth. It plays a crucial role in improving facial structure and aesthetics.

Good oral care is more than brushing and flossing. Nature offers powerful remedies and certain leaves can help fight bacteria ...

It may not just be tooth decay you need to worry about when it comes to sugary drinks: new research suggests that these ...

Structure Therapeutics Inc.’s GPCR share price has dipped by 12.27%, which has investors questioning if this is right time to buy.

On Wednesday, the Supreme Court heard oral arguments in Federal Communications Commission v. Consumers’ Research (consolidated with SHLB Coalition ...

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has been given an average rating of “Buy” by the eight research ...